Figure 2
Rates of recurrent malignancy, and risk of early and late recurrent malignancy according to GVHD condition. (A) Relapse rates were calculated within sequential 90-day intervals for patients without GVHD shown in green, for patients with grades II-IV GVHD without chronic GVHD shown in blue, and for patients with NIH chronic GVHD shown in red. Small symbols represent the actual relapse rates for each 90-day interval. The smoothed rates were plotted as curves for each condition. Low event rates account for large variations between sequential intervals after 36 months. (B-C) Risk of early and late recurrent malignancy according to GVHD condition. *Number of patients at risk in the condition at any time during the period of analysis. †Hazard ratios were adjusted for disease, risk category, and total body irradiation.

Rates of recurrent malignancy, and risk of early and late recurrent malignancy according to GVHD condition. (A) Relapse rates were calculated within sequential 90-day intervals for patients without GVHD shown in green, for patients with grades II-IV GVHD without chronic GVHD shown in blue, and for patients with NIH chronic GVHD shown in red. Small symbols represent the actual relapse rates for each 90-day interval. The smoothed rates were plotted as curves for each condition. Low event rates account for large variations between sequential intervals after 36 months. (B-C) Risk of early and late recurrent malignancy according to GVHD condition. *Number of patients at risk in the condition at any time during the period of analysis. †Hazard ratios were adjusted for disease, risk category, and total body irradiation.

Close Modal

or Create an Account

Close Modal
Close Modal